![Peter A. Zorn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter A. Zorn
President chez
Genevant Sciences, Inc.
Profil
Peter A. Zorn currently works at Genevant Sciences Corp., as Chief Operating Officer from 2019, Genevant Sciences, Inc., as President & Chief Legal Officer from 2020, and Womble Bond Dickinson (US) LLP.
Mr. Zorn also formerly worked at Targacept, Inc., as Secretary, SVP-Legal Affairs & General Counsel from 2010 to 2013, Roche Innovation Center Copenhagen A, as General Counsel & Vice President-Communications, and Albireo Pharma, Inc., as Secretary & General Counsel from 2015 to 2018.
Mr. Zorn received his undergraduate degree from Harvard University and graduate degree from The University of North Carolina at Charlotte.
Postes actifs de Peter A. Zorn
| Sociétés | Poste | Début |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur des opérations | 07/01/2019 |
Genevant Sciences, Inc.
 Genevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company | President | 01/07/2020 |
Anciens postes connus de Peter A. Zorn
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Conseiller Juridique Général | 01/04/2018 |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Conseiller Juridique Général | 30/09/2013 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Public Communications Contact | - |
Formation de Peter A. Zorn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Genevant Sciences, Inc.
Genevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company | Health Technology |
